carbamates has been researched along with erastin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Cullinan, DR; DeNardo, DG; Goedegebuure, SP; Hashim, YM; Hawkins, WG; Liu, J; Mach, RH; Nywening, TM; Ohman, KA; Spitzer, D; Tiriac, H; Tuveson, DA; Van Tine, BA; Vangveravong, S | 1 |
Alothaim, T; Charbonneau, M; Tang, X | 1 |
2 other study(ies) available for carbamates and erastin
Article | Year |
---|---|
Conjugation to the sigma-2 ligand SV119 overcomes uptake blockade and converts dm-Erastin into a potent pancreatic cancer therapeutic.
Topics: Animals; Antineoplastic Agents; Azabicyclo Compounds; Carbamates; Cell Line, Tumor; Disease Models, Animal; Drug Delivery Systems; Humans; Ligands; Mice; Mice, Inbred C57BL; Mice, Nude; Pancreatic Neoplasms; Piperazines; Receptors, sigma; Xenograft Model Antitumor Assays | 2016 |
HDAC6 inhibitors sensitize non-mesenchymal triple-negative breast cancer cells to cysteine deprivation.
Topics: Anilides; Carbamates; Cell Death; Cell Line, Tumor; Cysteine; Enzyme Activation; Epithelial Cells; Female; Gene Knockout Techniques; HEK293 Cells; Histone Deacetylase 6; Histone Deacetylase Inhibitors; Homeostasis; Humans; Hydroxamic Acids; Indoles; Neoplasm Proteins; Oxazoles; Piperazines; Protein Kinase C; Small Molecule Libraries; Transcription, Genetic; Transcriptome; Triple Negative Breast Neoplasms; Zinc | 2021 |